Jeff Augen has left his post as worldwide director of strategy for IBM’s Life Sciences business unit to join New Haven, Conn.-based TurboWorx (formerly TurboGenomics) as president. “I couldn’t pass up this opportunity to join a much smaller organization because TurboWorx’s intellectual property and software products are going to have an enormous impact on life science research efforts,”Augen said in a statement.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.